Matrix metalloproteinase inhibitors in rheumatic diseases.
about
Drugs in development: bisphosphonates and metalloproteinase inhibitorsSuppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.Tumor imaging by means of proteolytic activation of cell-penetrating peptidesMMP-3 and MMP-8 single-nucleotide polymorphisms are related to alcohol-induced osteonecrosis of the femoral head in Chinese males.Matrix Metalloproteinase Gene Activation Resulting from Disordred Epigenetic Mechanisms in Rheumatoid Arthritis.Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis.Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniationMatrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model.Tetraspanin CD9 promotes the invasive phenotype of human fibrosarcoma cells via upregulation of matrix metalloproteinase-9.Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031.The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis.Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro.High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis.c-Jun N-Terminal Kinase in Inflammation and Rheumatic Diseases.Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study.Selective and non-selective metalloproteinase inhibitors reduce IL-1-induced cartilage degradation and loss of mechanical properties.The Development of Novel Therapies for Rheumatoid ArthritisGenetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome.Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis.Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of osteoarthritisA novel approach to measure the contribution of matrix metalloproteinase in the overall net proteolytic activity present in synovial fluids of patients with arthritis.A comparison of the binding sites of matrix metalloproteinases and tumor necrosis factor-alpha converting enzyme: implications for selectivityTumor cell density regulates matrix metalloproteinases for enhanced migration
P2860
Q24795847-D1FA8D22-24EB-4C05-ABA8-323CB0C47B80Q33504871-99678A9D-1440-4203-84BE-C59A638DCF25Q33569121-D3662D94-7FD2-499A-986F-5EEF32C78BF7Q33648802-98B83224-A938-45BF-B05C-49A6880B73BDQ33754764-ADE1A14B-0F30-4CD7-AE8E-B6B8E3471821Q33880198-558CE080-F24F-4636-BC81-25D630CAF03AQ34413252-F845522F-4882-4075-9C62-BE0A06927475Q34614073-E4BF8E71-18B8-42A7-BAB4-B44BDBB2DF41Q34808021-1EE62FE1-3127-4618-B8D6-AB2928FFC47EQ35048514-1682FC44-5554-43C9-82F4-62FB2CC0A3A6Q35155417-F7921421-2021-45BB-BA07-5D4A6B2E711CQ35551055-16F5E8B0-9024-4DD2-8B1C-3EF744C7242BQ35869021-92EB1F9E-E287-47E0-BB55-D82910BE8797Q36286056-98CF2C96-268A-4C51-B353-4B7C03CD2154Q36401915-95C24F14-8EA2-4907-8D0A-A9F6DF21F5D9Q36688890-87F68E9F-E6EB-4DAA-B7CD-58446A1E4F2DQ36801049-8829F7E2-A266-44F4-9D5E-04AD246C66BBQ36908209-D8C3D092-FA2E-41F7-A9C2-329415442B3BQ37713247-EC20BFF5-6A28-4A19-B08E-6EA240DFAF34Q41531870-DE44367B-F745-44DE-9286-1E8E38442096Q41828378-157B6E1D-906B-4C91-A513-76119F3BB25FQ41973499-68B10EF2-C975-47A4-BF2F-2C06BDF49124Q58704679-CAD12043-937C-4129-A446-762A9147F0D7
P2860
Matrix metalloproteinase inhibitors in rheumatic diseases.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Matrix metalloproteinase inhibitors in rheumatic diseases.
@ast
Matrix metalloproteinase inhibitors in rheumatic diseases.
@en
Matrix metalloproteinase inhibitors in rheumatic diseases.
@nl
type
label
Matrix metalloproteinase inhibitors in rheumatic diseases.
@ast
Matrix metalloproteinase inhibitors in rheumatic diseases.
@en
Matrix metalloproteinase inhibitors in rheumatic diseases.
@nl
prefLabel
Matrix metalloproteinase inhibitors in rheumatic diseases.
@ast
Matrix metalloproteinase inhibitors in rheumatic diseases.
@en
Matrix metalloproteinase inhibitors in rheumatic diseases.
@nl
P2860
P1476
Matrix metalloproteinase inhibitors in rheumatic diseases.
@en
P2093
P2860
P304
P407
P478
60 Suppl 3
P577
2001-11-01T00:00:00Z